
    
      Phase III Clinical Study, prospective, multicenter, double-blind, randomized, double-dummy to
      assess the efficacy and safety of "Pílulas de Lussen®" compared to the Pyridium® in the
      symptomatic control of dysuria in 80 patients of either sex or race, older than 18 years,
      with symptoms of dysuria, 40 patients will receive the test medication (Pílulas de Lussen®)
      plus placebo and 40 patients will receive the comparative (Pyridium®) plus placebo to
      evaluate the effectiveness and tolerability of 'Pílulas de Lussen' for symptomatic relief of
      dysuria.
    
  